Mcpb

Mcpb

SCHEMBL1896022

Cc1cc(Cl)ccc1OCCCC(=O)[O-].[K+]

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Mcpb. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.68
TP53 P04637 1/20 0.68
ALOX15 P16050 1/20 0.68
ALDH1A1 P00352 3/20 0.67
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
HPGD P15428 4/20 0.61
RAB9A P51151 2/20 0.61
NPSR1 Q6W5P4 2/20 0.61
NPC1 O15118 1/20 0.61
GAA P10253 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C19 P33261 1/20 0.60
MAPT P10636 4/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
LMNA P02545 2/20 0.54
HTT P42858 1/20 0.51
TDP1 Q9NUW8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mcpb SCHEMBL15547896 0.97 KDM4E (0.68) KDM4ETP53ALOX15ALDH1A1MEN1
Potassium Ion SCHEMBL8441216 0.93 KDM4E (0.62) KDM4ETP53ALOX15ALDH1A1MEN1
SCHEMBL8443314 0.90 KDM4E (0.62) KDM4ETP53ALOX15ALDH1A1MEN1
SCHEMBL8438387 0.90 KDM4E (0.62) KDM4ETP53ALOX15ALDH1A1MEN1
SCHEMBL15547897 0.85 TSHR (0.54) KDM4ETP53ALOX15ALDH1A1MEN1
Potassium Ion SCHEMBL1890648 0.85 MAPT (0.67) TP53ALDH1A1MEN1KMT2AHPGD
Mcpb SCHEMBL29355091 0.85 KDM4E (0.72) KDM4ETP53ALOX15ALDH1A1MEN1
Mcpb SCHEMBL29150193 0.85 KDM4E (0.72) KDM4ETP53ALOX15ALDH1A1MEN1
Mcpb SCHEMBL117879 0.85 KDM4E (0.72) KDM4ETP53ALOX15ALDH1A1MEN1
SCHEMBL16244488 0.85 MEN1 (0.78) KDM4ETP53ALOX15ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9012363-B2 Granular controlled release agrochemical compositions and process for the preparation thereof EVERRIS INTERNATIONAL B.V. (NL) 2015-04-21 US disclosed
EP-1928231-B1 GRANULAR CONTROLLED RELEASE AGROCHEMICAL COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF EVERRIS INTERNAT B V (NL) 2014-03-12 EP disclosed
US-20130310255-A1 GRANULAR CONTROLLED RELEASE AGROCHEMICAL COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF OMS INVESTMENTS, INC. 2013-11-21 US disclosed
US-8497229-B2 Granular controlled release agrochemical compositions and process for the preparation thereof EVERRIS INTERNATIONAL B.V. (NL) 2013-07-30 US disclosed
EP-2545775-A2 Granular controlled release agrochemical compositions and process for the preparation thereof Everris International B.V. (NL) 2013-01-16 EP disclosed
EP-1370135-B1 CONTROLLED RELEASE PRODUCTS AND PROCESSES FOR THE PREPARATION THEREOF EVERRIS INTERNAT B V (NL) 2012-05-30 EP disclosed
US-20110111956-A1 Granular Controlled Release Agrochemical Compositions and Process for the Preparation Thereof OMS INVESTMENTS, INC. (US) 2011-05-12 US disclosed
EP-1928231-A2 GRANULAR CONTROLLED RELEASE AGROCHEMICAL COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF OMS Investments, Inc. (US) 2008-06-11 EP disclosed
WO-2007041234-A2 GRANULAR CONTROLLED RELEASE AGROCHEMICAL COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF OMS INVESTMENTS, INC. (US) 2007-04-12 WO disclosed
US-20070072775-A1 Granular controlled release agrochemical compositions and process for the preparation thereof OMS INVESTMENTS, INC. (US) 2007-03-29 US disclosed
US-6987082-B2 Controlled release products and processes for the preparation thereof OMS INVESTMENTS, INC. (US) 2006-01-17 US disclosed
US-20040069033-A1 Controlled release products and processes for the preparation thereof OMS INVESTMENTS, INC. 2004-04-15 US disclosed
EP-1370135-A1 CONTROLLED RELEASE PRODUCTS AND PROCESSES FOR THE PREPARATION THEREOF OMS Investments, Inc. (US) 2003-12-17 EP disclosed
US-6656882-B2 Coated products in particulate form which are structured to provide release profiles wherein initial release of active ingredients such as fertilizer nutrients is suppressed or for predetermined period and longevity for release within 60 days OMS INVESTMENTS, INC. 2003-12-02 US disclosed
US-20020168318-A1 Controlled release products and processes for the preparation thereof OMS INVESTMENTS, INC. 2002-11-14 US disclosed
WO-2002068363-A2 CONTROLLED RELEASE PRODUCTS AND PROCESSES FOR THE PREPARATION THEREOF OMS INVESTMENTS, INC. (US) 2002-09-06 WO disclosed
EP-0628527-B1 Timed release of water-soluble plant nutrients OMS INVESTMENTS INC (US) 2001-04-11 EP disclosed
US-5652196-A Timed release of water-soluble plant nutrients OMS INVESTMENTS, INC. (US) 1997-07-29 US disclosed
EP-0628527-A1 Timed release of water-soluble plant nutrients W.R. Grace & Co.-Conn. (US) 1994-12-14 EP disclosed
US-4015970-A FERTILIZER WITH POLYMERIC COATING AIRWICK INDUSTRIES, INC. (US) 1977-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040069033-A1 Controlled release products and processes for the preparation thereof GHITM, LBR, VMA21 KDM4E 1343/4885TP53 1310/4885ALOX15 2881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.